Related Experiment Video

Updated: May 17, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

Marked Regression of Left Ventricular Hypertrophy after Outflow Desobliteration in HOCM

Zisis Dimitriadis1, Frank van Buuren, Nikola Bogunovic

  • 1Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University of Bochum, Georgstraße 11, 32545 Bad Oeynhausen, Germany.

Case Reports in Medicine
|October 20, 2012
PubMed

Insights

Percutaneous septal ablation significantly reduced left ventricular hypertrophy in a hypertrophic obstructive cardiomyopathy patient. Wall thickness decreased, mitigating a key risk factor for implantable cardioverter-defibrillator implantation.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by left ventricular hypertrophy.
  • Significant left ventricular hypertrophy can be a risk marker for sudden cardiac death, necessitating interventions like implantable cardioverter-defibrillator (ICD) implantation.
  • Percutaneous septal ablation is an interventional procedure aimed at reducing outflow obstruction in HOCM.

Purpose of the Study:

  • To present a case of HOCM with significant regression of left ventricular hypertrophy after percutaneous septal ablation.
  • To evaluate the impact of septal ablation on cardiac structure and a key risk marker for ICD implantation.

Main Methods:

  • A patient with HOCM underwent percutaneous septal ablation for outflow desobliteration.
  • Cardiac imaging (echocardiography and MRI) was used to assess maximum wall thickness before and after the procedure.
  • Follow-up imaging monitored changes in left ventricular hypertrophy over two years.

Main Results:

  • Left ventricular hypertrophy showed marked regression following septal ablation.
  • Maximum wall thickness decreased from 34 mm to 22 mm within two years.
  • The reduction in wall thickness fell below the 30 mm threshold, a prior risk marker for ICD implantation.

Conclusions:

  • Percutaneous septal ablation can lead to substantial regression of left ventricular hypertrophy in HOCM.
  • Septal ablation may alter the risk profile for sudden cardiac death by reducing hypertrophy.
  • This intervention offers a potential therapeutic option for managing structural changes in HOCM.

More Related Videos

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...